Q BioMed
(OTC) QBIO
Q BioMed Financials at a Glance
Market Cap
$14,500
Revenue (TTM)
$211.79K
Net Income (TTM)
$1.23M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-6.05 (Low)
Dividend
$0.00
Beta (Volatility)
-6.05 (Low)
Price
$0.00
Volume
1,750
Open
$0.00
Price
$0.00
Volume
1,750
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.03
Dividend
$0.00
Beta (Volatility)
-6.05 (Low)
Price
$0.00
Volume
1,750
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.03
QBIO News
QBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Q BioMed
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Denis D. Corin
Website
www.qbiomed.comHeadquarters
New York City, NY 10017, US
QBIO Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-12%
Net Income Margin
-7%
Return on Equity
0%
Return on Capital
75%
Return on Assets
-58%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.50K
Shares Outstanding
145.09M
Volume
1.75K
Short Interest
0.00%
Avg. Volume
9.51K
Financials (TTM)
Gross Profit
$8.99K
Operating Income
$3.45M
EBITDA
$617.63K
Operating Cash Flow
$1.94M
Capital Expenditure
$4.00
Free Cash Flow
$1.94M
Cash & ST Invst.
$49.97K
Total Debt
$4.11M
Q BioMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.50K
-96.7%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$14.50K
N/A
Market Cap/Employee
$4.83K
N/A
Employees
3
N/A
Net Income
$826.41K
+75.8%
EBITDA
$432.51K
+76.8%
Quarterly Fundamentals
Net Cash
$4.06M
-26.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$4.08M
+22.0%
Return on Assets
-58.37%
N/A
Return on Invested Capital
74.62%
N/A
Free Cash Flow
$138.19K
+63.3%
Operating Cash Flow
$138.19K
+63.3%